Confluence Investment Management LLC Sells 10,846 Shares of The Clorox Company (NYSE:CLX)

Confluence Investment Management LLC cut its position in The Clorox Company (NYSE:CLX - Free Report) by 1.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 860,389 shares of the company's stock after selling 10,846 shares during the quarter. Clorox comprises about 1.9% of Confluence Investment Management LLC's portfolio, making the stock its 11th biggest holding. Confluence Investment Management LLC owned approximately 0.70% of Clorox worth $139,736,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Rothschild Investment LLC bought a new position in Clorox during the 2nd quarter worth $52,000. Summit Financial LLC raised its stake in Clorox by 13.5% in the second quarter. Summit Financial LLC now owns 3,212 shares of the company's stock valued at $438,000 after purchasing an additional 382 shares in the last quarter. Natixis Advisors LLC lifted its position in Clorox by 36.3% during the second quarter. Natixis Advisors LLC now owns 58,637 shares of the company's stock worth $8,002,000 after purchasing an additional 15,620 shares during the period. Versor Investments LP acquired a new stake in Clorox during the second quarter worth about $731,000. Finally, Rhumbline Advisers increased its holdings in Clorox by 1.5% in the 2nd quarter. Rhumbline Advisers now owns 277,321 shares of the company's stock valued at $37,846,000 after buying an additional 3,992 shares during the period. Institutional investors own 78.53% of the company's stock.

Analysts Set New Price Targets

CLX has been the topic of a number of recent analyst reports. Barclays lifted their price objective on shares of Clorox from $137.00 to $139.00 and gave the company an "underweight" rating in a research note on Friday, November 1st. Evercore ISI lowered their price target on Clorox from $140.00 to $139.00 and set an "underperform" rating for the company in a report on Monday, October 14th. DA Davidson raised their price objective on Clorox from $153.00 to $171.00 and gave the company a "neutral" rating in a research note on Monday, November 4th. BNP Paribas raised Clorox to a "strong sell" rating in a research note on Friday, September 6th. Finally, TD Cowen upgraded shares of Clorox from a "sell" rating to a "hold" rating and raised their price target for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Five equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $155.38.

Clorox Trading Down 0.4 %

NYSE:CLX traded down $0.58 on Thursday, reaching $161.83. 714,304 shares of the stock traded hands, compared to its average volume of 1,227,744. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The firm has a market capitalization of $20.03 billion, a price-to-earnings ratio of 56.39, a price-to-earnings-growth ratio of 3.04 and a beta of 0.42. The company's 50 day moving average is $164.45 and its 200-day moving average is $154.62. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same period in the prior year, the firm earned $0.49 earnings per share. Clorox's revenue was up 27.0% on a year-over-year basis. Equities research analysts anticipate that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.02%. The ex-dividend date is Wednesday, January 29th. Clorox's dividend payout ratio (DPR) is presently 170.03%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.